Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1613 (118th)

Drug Price Transparency in Medicaid Act of 2023

referredUnited States· United States Congress· EN

Introduced

17 March 2023

Last action

24 March 2023 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Gonzalez, Vicente [D-TX-34], Rep. Stefanik, Elise M. [R-NY-21], Rep. Ross, Deborah K. [D-NC-2], Rep. Allen, Rick W. [R-GA-12], Rep. Auchincloss, Jake [D-MA-4], Rep. Mills, Cory [R-FL-7], Rep. Krishnamoorthi, Raja [D-IL-8], Rep. Trone, David J. [D-MD-6], Rep. Williams, Roger [R-TX-25], Rep. Malliotakis, Nicole [R-NY-11], Rep. Harshbarger, Diana [R-TN-1], Rep. Langworthy, Nicholas A. [R-NY-23], Rep. Peters, Scott H. [D-CA-50], Rep. Miller-Meeks, Mariannette [R-IA-1], Rep. Alford, Mark [R-MO-4], Rep. Harris, Andy [R-MD-1], Rep. Tlaib, Rashida [D-MI-12], Rep. Thompson, Glenn [R-PA-15], Rep. Bishop, Sanford D. [D-GA-2], Rep. Bacon, Don [R-NE-2], Rep. Lawler, Michael [R-NY-17], Rep. Mann, Tracey [R-KS-1], Jerry Carl, Rep. Dunn, Neal P. [R-FL-2], Rep. Perez, Marie Gluesenkamp [D-WA-3], Rep. Rogers, Mike D. [R-AL-3], Rep. Meuser, Daniel [R-PA-9], Rep. Ryan, Patrick [D-NY-18], Rep. Graves, Garret [R-LA-6], Rep. Santos, George [R-NY-3], Rep. Bentz, Cliff [R-OR-2], Rep. LaLota, Nick [R-NY-1], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Cartwright, Matt [D-PA-17], Rep. Edwards, Chuck [R-NC-11], Rep. Budzinski, Nikki [D-IL-13], Rep. Morelle, Joseph D. [D-NY-25]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Drug Price Transparency in Medicaid Act of 2023 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 17 March 2023

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 17 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 17 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 24 March 2023

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 17 March 2023

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 17 March 2023

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 17 March 2023

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.